We’re proud to make a difference.
Personalized care for patients with psychiatric disorders.
Guidance, in days, not weeks.
Receive comprehensive guidance to support your treatment plan.
Simplify your work.
Simplify referrals, assessments, and outcome tracking. We take care of all of it.
Actionable guidance for each patient.
Timely, evidence-based guidance, personalized to each patient.
Subscribe to Soli
Soli supports timely, personalized care for patients with mood disorders, anxiety, insomnia, or ADHD.
Individual clinicians are invited to register to request comprehensive and evidence-based guidance, personalized to your patient.
Joining is quick and easy.
Patients get care sooner
We deliver personalized & actionable guidance within days of a completed referral - so you can provide rapid access to care.
Health outcomes you can see
Automated patient scales at intake and 6-week intervals give you a visual record of their progress — with clear guidance on recommended action.
Simplify your work
We remove the burden of requesting and collecting clinical scales, researching treatments and tracking outcomes, so you can provide efficient and effective care.
Everything you need in one personalized and actionable report.
Diagnostic and treatment guidance for major depressive disorder, generalized anxiety disorder, bipolar disorder, ADHD, and insomnia. Quick and easy, right from your EMR.
-
Diagnostic guidance: Support effective treatment pathways. -
Personalized treatment: Tailored to your patient. -
Medication management: Actionable guidance for dosing, titration, side effect management. -
Ongoing assessments: Automated follow-up scales. -
Empowered patients: Resources to support adherence and understanding.
Guidance you can trust.
Soli guidance is informed by the authoritative guide to the assessment and diagnosis of mental disorders (DSM-5-TR), validated clinical scales, peer-reviewed treatment guidelines, and the latest high-quality empirical research.
Dr. Diane McIntosh, co-founder of Rapids Health and SwitchRx, is a psychiatrist and expert in the diagnosis and treatment of mood and anxiety disorders. A respected psychiatrist, author, and educator, Diane is a passionate advocate for better mental health care and a tireless champion for those suffering from mental health challenges. Diane believes every individual deserves access to the best mental health care possible so they can live full lives with physical and mental well-being.
Soli has been developed by experts in psychiatry and psychopharmacology, with the support and input from clinicians in everyday practice. Experts include leaders and researchers in psychiatric disorders and psychotropic medications who hold senior positions with leading academic and research institutions.
Our process involves rigorous evaluation of evidence and guidelines and validation of rules and logic during hundreds of hours of clinical review. The knowledge base and rules are curated, evaluated, and validated by clinical experts to ensure they reflect the psychiatric standards of care accurately.
Soli draws on empirical evidence supporting a treatment’s efficacy and tolerability. Soli-preferred pharmacological options are those with a significant body of empirical evidence demonstrating efficacy as well as strong tolerability profile, supported by reputable treatment guidelines and expert clinical experience.
Soli guidance is informed by the authoritative guide to the assessment and diagnosis of mental disorders (DSM-5-TR), validated clinical scales, peer-reviewed treatment guidelines, and the latest high-quality empirical research.
Dr. Diane McIntosh, co-founder of Rapids Health and SwitchRx, is a psychiatrist and expert in the diagnosis and treatment of mood and anxiety disorders. A respected psychiatrist, author, and educator, Diane is a passionate advocate for better mental health care and a tireless champion for those suffering from mental health challenges. Diane believes every individual deserves access to the best mental health care possible so they can live full lives with physical and mental well-being.
Soli has been developed by experts in psychiatry and psychopharmacology, with the support and input from clinicians in everyday practice. Experts include leaders and researchers in psychiatric disorders and psychotropic medications who hold senior positions with leading academic and research institutions.
Our process involves rigorous evaluation of evidence and guidelines and validation of rules and logic during hundreds of hours of clinical review. The knowledge base and rules are curated, evaluated, and validated by clinical experts to ensure they reflect the psychiatric standards of care accurately.
Soli draws on empirical evidence supporting a treatment’s efficacy and tolerability. Soli-preferred pharmacological options are those with a significant body of empirical evidence demonstrating efficacy as well as strong tolerability profile, supported by reputable treatment guidelines and expert clinical experience.
Hear how Rapids has supported clinicians in their patient care.
I de-escalated all her medications and this young woman has her life back. Rapids can be life changing and clinicians should use it as much as they can - it can really help them and their patients.
Rapids is like your personal assistant, it will do all the evidence-based analysis needed for your patient and present you with the best, personalized treatment options and follow-up.
Quick response by patient and fast report delivery! Physicians were shocked by how quickly patients responded and reports were delivered, different from standard referrals.
I use Rapids because the surveys monitor the effectiveness of new medication starts.
When I first started, I did what most health practitioners do - conduct multiple assessments, which can take days. So before I even got to a diagnosis, there were hours of time invested. Today, a Rapids assessment takes just 15 minutes.
I use Rapids because it provides diagnostic and treatment clarity and helps reduce trial and error in finding the best medication.
Rapids saves a huge amount of time and stress for our clients when looking for appropriate diagnosis and treatment in the community.
When I need a referral for a complex case, it can take 7 different referral requests until I find a specialist whose wait list is not full. Rapids can turn around a referral for a complex case in less than 2 days.
FAQ – Your questions, answered.
Answers to common inquiries about products from Rapids Health.
Browse by Category
Ori
Ori by Rapids Health is an AI-powered clinical decision support tool that makes evidence-based and expert-informed psychiatric knowledge available to clinicians.
Keeping up-to-date with evolving psychiatric knowledge can be difficult. It takes time to sift through resources, and specialist consults can be hard to get. Ori delivers trusted, evidence-based and expert-informed guidance instantly, so you can more effectively help your patients – without the wait.
At this time, you can ask questions about psychiatric medications and decision support related to pharmacotherapy, as well as questions related to clinical presentations to generate structured treatment guidance for MDD and GAD. New disorders will be added soon.
Ori provides guidance related to major depressive disorder (MDD) and generalized anxiety disorder (GAD). Guidance related to insomnia, ADHD, and bipolar disorder will be added in the coming months.
The Rapids knowledge base is a curated repository of clinical information on psychiatric medications and comprehensive treatment guidance sourced from published guidelines, peer-reviewed research, and clinical expertise. The knowledge has been selected by leaders in the field of psychiatry and psychopharmacology and logic-driven treatment guidance has been validated by a panel of psychiatric experts.
Ori is an AI-powered clinical decision support tool that makes evidence-based and expert-informed psychiatric knowledge accessible instantly, safely, and in context, to support confident and informed clinical decision-making. Soli (known to many as RAPIDS) is a clinical decision support service that automates patient assessments and provides evidence-based treatment and diagnostic guidance, in a report, personalized for each patient.
Information about Ori is updated regularly; go here to test Ori or join our beta waitlist.
Soli (Rapids)
Soli is the new name for Rapids, our clinical decision support service that provides personalized diagnostic and treatment guidance in a detailed report to support clinical decision-making.
Using clinical scales is standard psychiatric care. Soli automates scale delivery, streamlines the collection of patient information to support a DSM-5-TR diagnosis, and automates follow-up monitoring. Evidence-based, clinically informed guidance reduces administrative burden, accelerates treatment decisions, and provides patient education to support engagement, shared decision-making, and adherence.
Patients aged 18-65 with symptoms of mood disorders (MDD and bipolar), anxiety, insomnia and/or ADHD can benefit from Soli.
Soli subscribers have access to Soli smart forms for the following EMRs: Accuro, CHR, Juno, MedAccess, Medesync, MOIS, Myle, PS Suite, Oscar, Plexia and Profile.
Soli (the product you know as RAPIDS) will continue to run exactly as it always has. We have updated the name and brand to bring it in line with our new solution, Ori, that is now available for testing. We’ve launched a new website, and we now offer online access to customer support and resources. Summary of changes:
- the product is now called Soli
- we have updated our brand (you may have noticed, the website looks quite different!)
- you can contact us now through our new service desk (i.e. not via email)
- the Terms and Conditions have been updated.
You should receive communications from Rapids in your email about these changes and the updated Terms of Use. If you have not, please contact us.
Soli (known to many as Rapids) is a clinical decision support service that automates patient assessments and provides evidence-based treatment and diagnostic guidance, in a report, which is personalized for each patient. Ori is a new AI-powered clinical decision support tool that makes evidence-based and expert-informed psychiatric knowledge accessible instantly, safely, and in context, to support confident and informed clinical decision-making.
Yes, Rapids – now Soli – is available. See here to subscribe.
Early access
We’re inviting eligible users to join our alpha program and join the waitlist for early access to Ori when beta is released this spring. Learn more
We are recruiting for eligible users to join the alpha test group for Ori now. Currently eligible are Canadian family physicians and nurse practitioners. Ori will be available in beta to a broader group of Canadian prescribers starting Spring 2026; please join the waitlist to be first in line – no cost involved.
There is no cost for Ori or Soli at this time.
Not ready to join the alpha and beta programs? Want to keep up with exciting product updates? Join our mailing list and we’ll keep you updated.
